The trajectory of the erectile dysfunction drug presents a intricate picture for investors. While the initial release generated massive returns, the expiration of its patent opened the floodgates to generic https://tbookmark.com/story21502220/the-copyright-and-the-pharmaceutical-industry-a-volatile-investment